sign in sign up
<<
Home , Hyperandrogenism, Hyperthecosis

158 KUWAIT MEDICAL JOURNAL June 2015

Case Report Postmenopausal Ovarian

Sundus AlDuaiJ1, Suha Abdulsalam2, Khulood Al Asfore2 1Department of , Mubarak Al Kabeer Hospital, Kuwait 2Department of Medicine, Mubarak Al Kabeer Hospital, Kuwait

Kuwait Medical Journal 2015; 47 (2): 158 - 160

ABSTRACT

Ovarian hyperthecosis has variable clinical importance. It secreted by ovarian stromal cells is greatly can cause , particulary in premenopausal increased with hyperplastic or neoplastic transformation women, and may be a rare cause of androgenic alopecia leading to possible clinical consequences. We report a case of in postmenopausal women. The physiological level of postmenopausal ovarian hyperthecosis.

KEY WORDS: hyperandrogenism, postmenopausal

INTRODUCTION Physical examination revealed temporal and The term hyperthecosis refers to the presence of anterior baldness and increase facial hair on her nests of luteinized theca cells in the ovarian stroma sideburns and chins. She was overweight with body mass index of 28 kg/m2. Examination of the chest, into steroidogenically active luteinized stromal cells. heart, abdomen and pelvis were otherwise normal. The nests or islands of luteinized theca cells are Initial investigation showed normal full blood as in the polycystic syndrome. The result revealed raised serum total 401 nmol/l (0.3 is greater production of androgens. It is not clear - 3.0), with sex hormone binding globulin 15 nmol/l why hyperthecosis occur. Bilateral ovarian stromal (20 - 118), dehydroepiandrosterone sulfate 7.4 nmol/l hyperthecosis occasionally causes in (0.9 - 11.7) and androstenedione 22.4 nmol/l (1.6 - 9.4). premenopausal women[1]. However, a previous The gonadotrophins which are luteinizing hormones review article found only two previously reported and follicular stimulating hormone (FSH) were in the cases of stromal hyperthecosis in postmenopausal postmenopausal range, whereas the serum estradiol women[2]. level was slightly elevated for postmenopausal state (340 pmol/l). Thyroid function tests were normal. CASE REPORT The results of further diagnostic tests were as A 54-year-old Kuwaiti female, reaching follows: morning serum after overnight dexamethasone suppression test (1 mg) was normally suppressed (20 nmol/l). Short synacthen test (250 years history of and frontal . She micrograms cortisone intravenously) was done to was known to have type 2 and , exclude the diagnosis of late onset congenital adrenal had at age 13 and described that she had hyperplasia (Table 1). since menarche and , but had two successful pregnancies after clomiphene treatment. (1.6 nmol/l), but only partial suppression of testosterone On October 2010, she had partial gastrectomy due (2.8 nmo/l) followed low dose dexamethasone to stomach followed by chemotherapy and therapy (0.5 mg 4 times a day for 5 days). Ultrasound currently, the patient is in remission. examination of adrenals and transvaginal ultrasound

Address correspondence to: Sundus AL Duaij, Department of Endocrinology, Mubarak Al Kabeer Hospital, Kuwait. Tel: +965-99734486 (M), [email protected] June 2015 KUWAIT MEDICAL JOURNAL 159

Table 1: Short synacthen test (250 micrograms cortisone occurs mainly in association with resistance intravenous) to exclude the diagnosis of late onset congenital that manifest with central , hypertension, adrenal hyperplasia , and or impaired glucose tolerance[7,8], as was the case in Time Cortisol 17 hydroxyprogesterone nmol/l nmol/l our patient . 0 323 1.6 Imaging is required to rule out ovarian neoplasm 30 683 14 and to measure endometrial thickness, as there is 60 763 14 an association between ovarian hyperthecosis and endometrial cancer[9]. As described in a previous of were normal. Magnetic resonance image of study, it is likely to be related to increased abdomen and pelvis was normal. production by the luteinized theca cells, which then In view of these clinical and biochemical serve as precursors for production([0-12]. observations, a diagnosis of ovarian hyperthecosis Sonographic features of ovarian hyperthecosis are (severe variant of polycystic ovary syndrome) was made. as was the case in our patient. A small percentage of The patient subsequently received and metformin treatment. At the same time, she started features of polycystic ovary syndrome and infrequently laser therapy with improvement in her hirsutsim. a small solid mass may be seen[13]. Treatment of hyperthecosis should include weight reduction, DISCUSSION insulin sensitizing agents such as metformin and We describe a case of postmenopausal thiazolidinedies. However, hirsutism can be controlled hyperthecosis, a severe variant of polycystic ovary by therapy that includes spironolactone syndrome who presented with hirsutism and and gonadotropin releasing hormone agonists. If responded well to antiandrogen therapy. patient is in the reproductive age, oral contraceptive Ovarian hyperthecosis is characterized by pills can be used or clomiphene, if she seek fertility. theca cells[3]. It is an uncommon disorder with CONCLUSION androgen overproduction. Ovarian hyperthecosis Although ovarian hyperthecosis is a recognized shares many clinical features with polycystic ovary cause of premenopausal virilization, it should also syndrome including hirsutism, and menstrual be included as an unusual cause of postmenopausal irregularities. However, it tends to be more likely virilization. The demonstration that this syndrome associated with virilisation[4]. Most women with can develop in the postmenopausal period, as in our ovarian hyperthecosis are obese, with long standing patient, strongly suggest that it is a distinct entity and history of hirsutism. The hirsutism is usually severe not a late stage of polycystic ovary syndrome, as has and most of the women shave daily. Many also have been suggested. clitoral enlargement, temporal balding, deepening of the voice and a male habitus. Most have REFERENECES and the remaining have irregular anovulatory cycles. Acanthosis nigrican is suggestive of severe insulin 1. Goldman JM, Kapadia LJ. Virilization in resistance. postmenopausal women due to ovarian stromal Despite marked hyperandrogenism as in our hyperthecosis .Postgrad Med J 1991; 67:304-306. case, mainly testosterone is elevated in most cases 2. Van Heyningen C, MacFarlane IA, Diver MJ, Muronda and postmenopausal ovarian hyperthecosis generally presents as a non-neoplastic, functional disorder, in a postmenopausal women. Gynecol Endocrinol which result from abnormal regulation of ovarian 1988; 2:331-338. steroidogenesis[5]. 3. Rajput R, Bhansali A, Singh A. Ovarian hyperthecosis Unlike polycystic ovary syndrome, which occurs and response to : An uncommon only during the reproductive years, hyperthecosis presentation of a common disorder. J Obstet Gynaecol of the ovaries can occur in postmenopausal women. 2008; 28:249-250. Severe hirsutism and virilization in postmenopausal 4. Ashaweah K, Aghilla MM, Randeva HS. Androgenic women are more often due to ovarian hyperthecosis alopecia in postmenopausal ovarian hyperthecosis. J than virilizating ovarian tumor[6], which is an ovarian Obstet Gynaecol 2011; 31:351-352. tumor made up of hormone secreting cells due to 5. Krug E, Berga SL. Postmenopausal hyperthecosis excessive male hormone (androgen) production. functional dysregulation of androgenesis in climacteric Previous reports suggest that ovarian hyperthecosis ovary. Obstet Gynecol 2002; 99:893-897. 160 Postmenopausal Ovarian Hyperthecosis June 2015

6. Efstathiadou Z, Tsatsoulis A. Long-term remission of ovarian hyperandrogenism after short-term treatment Endometrial cancer. In : Kurman RJ, Editor. Blaustein’s with a gonadotropin-releasing hormone agonist. Fertil Pathology of the Female Genital Tract 5th ed. New York: steril 2001; 75:59-62. Springer 2002; 5:501-559. 7. Nagamani M, Dinh T, Kelver ME. Hyperinsulinemia in 12. Jongen VH, Hollema H, van der Zee AG, Santema hyperthecosis of the ovaries. Am J Obstet Gynecol 1996; JG, Heineman MJ. Ovarian stromal hyperplasia and 154:384-387. ovarian vein levels in relation to endometroid endometrial cancer. BJOG 2003; 110:690-695. diabetes and hirsutes in postmenopausal women. Clin 13. Brown DL, Henrichsen TL, Clayton AC, et al. Ovarian Endocrinol 1997; 46:123-128. stromal hyerthecosis: Sonographic features and 9. Clement PB, Kurman RJ. Non-neoplastic lesion of the histological association. J Ultrasound Med 2009; 28:587- ovary. Blaustein’s Pathology of the Female Genital 593. Tract 2002; 5:675-728. 10. Sasono H, Fukunaga M, Silverberg SG. Hyperthecosis of the ovary. Int J Gynecol Pathol 1989; 96:311-320.